Celldex Therapeutics, Inc. (NASDAQ:CLDX)’s shares decreased 1.86% to $13.17. The company on June 2 reported data from its ongoing Phase 1 study of the fully human...
InterMune, Inc. (NASDAQ:ITMN)’s shares dropped 2.53% to $42.83. The company on July 3 announces that the U.S. Food and Drug Administration (the “FDA”) has acknowledged receipt...
CytRx Corporation (NASDAQ:CYTR)’s shares gained 4.15% to $3.77. Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti,...